SPRO Spero Therapeutics, Inc. Company Cash Funds

Graphic logo of sperotherapeutics.com (SPRO)

The potential for monopoly revenues from antibiotic patents is driving the cash balance dynamics of Spero Therapeutics (SPRO). The foundation of Spero Therapeutics (SPRO) rests on the deep scientific expertise of its staff and business protection provided by stringent FDA requirements. The current level of 0.11 shows the value of this metric, allowing for an assessment of liquidity resilience against Fed rates and inflationary risks on this chart.

Company Total Cash Volume: Spero Therapeutics Inc (SPRO) for 07/04/2022 - 11/21/2026

Financial and market metric breakdowns for Spero Therapeutics Inc (SPRO)

- stock value and consensus price forecast:
Analysis of all company metrics:Spero Therapeutics SPRO
Signature product of Spero Therapeutics, Inc.

This indicator assesses the liquid safety cushion, determining the business's ability to fund development or service debt without external borrowing. Analyzing the current size of cash assets allows for the identification of the stage between capital accumulation and expansion, which is critical for Spero Therapeutics (SPRO) when scaling antibiotic supplies to the hospital sector to ensure long-term operational sustainability.